drugset / Trial / NCT03443804

To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients

NCT03443804

Phase 3 Completed 462 enrolled Daewon Pharmaceutical Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

Evaluate the Efficacy and Safety of DW1401 versus Stillen tab. in Patients with Acute or Chronic Gastritis

Timeline

Start
2014-07
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject DW1401 Unknown Oral
Comparator Stillen Unknown Oral

Indications